HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

berdazimer sodium

nitric oxide (NO) releasing polysiloxane macromolecule

Also Known As:

NVN1000

Networked: 3 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Stasko, Nathan: 2 articles (10/2018 - 01/2018)
2.	Berman, Brian: 1 article (10/2018)
3.	Durham, Todd: 1 article (10/2018)
4.	Maeda-Chubachi, Tomoko: 1 article (10/2018)
5.	Rosen, Theodore: 1 article (10/2018)
6.	Tyring, Stephen K: 1 article (10/2018)
7.	Doxey, Ryan: 1 article (01/2018)
8.	Hollenbach, Stanley J: 1 article (01/2018)
9.	Martin, Megan: 1 article (01/2018)
10.	McHale, Kimberly: 1 article (01/2018)

Related Diseases

1.	Warts (Wart) 10/01/2018 - "Topical SB206 (berdazimer sodium plus carboxymethyl cellulose hydrogel) was assessed for tolerability, safety, and efficacy for up to12 weeks in patients with external genital and/or perianal warts (EGW/PAW) in a phase 2, double-blind, randomized, dose-escalation study. "
2.	Mycoses (Diseases, Fungus) 01/01/2018 - "The Nitricil technology platform is comprised of polysiloxane-based macromolecules that stably release therapeutic levels of NO. In the reported studies, NVN1000, the lead candidate of the platform, was assessed for its spectrum of in vitro activity against a broad range of filamentous fungi and yeast species commonly associated with cutaneous fungal infections. "
3.	Molluscum Contagiosum 01/01/2023 - "The Berdazimer Sodium In Molluscum Patients with LEsions (B-SIMPLE4) phase III study enrolled 891 patients with molluscum contagiosum. "

Related Drugs and Biologics

1.	Hydrogels
2.	Carboxymethylcellulose Sodium (Polycell)
3.	Siloxanes (Siloxane)